Grepafloxacin hydrochloride, also known as OPC-17116 hydrochloride, is an orally active fluoroquinolone antibiotic. It demonstrates potent activity against common community-acquired respiratory pathogens, including *Streptococcus pneumoniae*. This compound is characterized by its high tissue penetration and a favorable pharmacodynamic profile, making it a promising agent for research into antibiotic treatments.
- Potent activity against community-acquired respiratory pathogens.
- Effective against *Streptococcus pneumoniae*.
- Exhibits high tissue penetration.
- Possesses a promising pharmacodynamic profile.
- Demonstrates in vitro antibacterial activity against Gram-positive bacteria.
- Shows in vivo efficacy in experimental systemic infections caused by Gram-positive and Gram-negative bacteria.